KATHERINE KING

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address1102 BATES
Houston, TX 77030
ORCID ORCID Icon0000-0002-5093-6005 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Harvard University, CambridgeAB06/1996Biochemical Sciences
    Washington University, St. LouisMD PhD06/2003Molecular Microbiology and Microbial Pathogenesis
    Baylor College of Medicine, Houstonresidency06/2006Pediatrics
    Baylor College of Medicine, Houstonfellowship06/2010Infectious Diseases
    Collapse awards and honors
    2015 - 2017Liviya Anderson Research Award, Aplastic Anemia and MDS International Foundation
    2015 - 2017Basil O'Connor Starter Scholar Award, March of Dimes
    2014 - 2015BCM Junior Faculty Seed Grant, Caroline Wiess Law Fund for Research in Molecular Medicine
    2010 - 2015KO8 Mentored Clinical Scientist Training Award, NIH
    2011 - 2012Pediatric Pilot Award, Texas Children's Hospital
    2008 - 2009Collaborative Research Grant, L.E. and Virginia Simmons Family Foundation
    2017 - 2018New Member Outstanding Science Award, Society for Pediatric Research
    2017 - 2018Woman of Excellence Award, Baylor College of Medicine
    2019Presidential Early Career Award for Scientists and Engineers (PECASE), President of the United States
    2020Distiguished Alumni Award, St. John's School
    2021 - 2028Emerging Investigator Award, NIH NHLBI
    2022Research Mentorship Award, Department of Pediatrics, BCM and TCH
    2022DeBakey Research Award, Baylor College of Medicine

    Collapse Overview 
    Collapse overview
    Katherine Y. King MD PhD is an Associate Professor of Pediatric Infectious Diseases at Baylor College of Medicine, where she is also part of the faculty for the Stem Cells and Regenerative Medicine Center, the Center for Cell and Gene Therapy, and the graduate programs in Immunology, Developmental Biology, and Translational Biology and Molecular Medicine. A native Houstonian, Dr. King received her BA in Biochemical Sciences from Harvard University and her MD and PhD degrees from Washington University in St. Louis. She completed her residency, chief residency, and fellowship training in Pediatric Infectious Diseases at Baylor College of Medicine. She is now the Associate Vice Chair for Research in the Department of Pediatrics and the Co-Director of the Medical Scientist Training Program at BCM.
    The long-term goal of Dr. King’s research is to alleviate deaths from infectious diseases. Given that severe infections are frequently related to weaknesses in the immune system, Dr. King’s research focuses on the molecular mechanisms by which inflammation affects blood and immune cell production by hematopoietic stem cells in the bone marrow. Dr. King has been the recipient of a NIH K08 mentored physician scientist training award, the March of Dimes Basil O’Connor Starter Scholar Award, the Aplastic Anemia and MDS International Foundation Liviya Anderson Award, the Presidential Early Career Award for Scientists and Engineers (PECASE), and the DeBakey Research Award. She is a member of the American Society for Clinical Investigation and the American Pediatric Society. Her research has been published in highly regarded journals such as Cell Stem Cell, Cell Reports, and Blood.

    Current projects in the lab include:
    Impact of Infection and Inflammation on Hematopoiesis
    We are studying how infections affect the quiescence, epigenetic programming, and differentiation of hematopoietic stem cells and their progeny. Our studies may lead to ways to prevent bone marrow suppression after chronic infections or enhance trained immunity. Funding to support this project: NIH R35, 2021-2028

    The Role of Infection and Inflammation in Clonal Hematopoiesis
    We are studying how the differential responses of hematopoietic stem cells to inflammation contribute to clonal competition and emergence of leukemia. These studies provide a mechanistic understanding of how infections affect cancer risk. Funding to support this project: NIH P01, 2022-2027

    Microbiota-dependent Regulation of Primitive Hematopoiesis
    An adverse side effect of antibiotics is that they may suppress blood and immune cell production by the bone marrow. We demonstrated that these adverse effects of antibiotics are due to disruption of the intestinal microbiome and associated type I interferon signaling. Our current work will define the molecular pathways through which the microbiome signals to support normal blood production. Funding to supporting this project: NIH R01 (co-I), 2018-2023

    Collapse Research 
    Collapse research activities and funding
    5P01CA265748     (Goodell, Margaret)Apr 1, 2022 - Mar 31, 2027
    NIH
    Modifiable Drivers of Expansion and Malignant Transformation from Clonal Hematopoiesis
    Role Description: The overall goal of this Program, with three interactive Projects and two Cores, is to identify modifiable risk factors of CH-associated HSPC expansion and subsequent malignant transformation, with a long-term view toward developing cancer prevention strategies.
    Role: Project 1 Lead, Administrative Core Co-Lead

    R35HL155672     (KING, KATHERINE YUDEH)Jul 1, 2021 - Jun 30, 2028
    NIH
    Impact of Infection and Inflammation on Primitive Hematopoiesis
    Role: Principal Investigator

    T32GM136611     (KING, KATHERINE YUDEH)Jul 1, 2020 - Jun 30, 2025
    NIH
    Medical Scientist Training Program
    Role: Principal Investigator

         (Margaret Goodell)Jul 1, 2019 - Jun 30, 2022
    Helis Medical Research Foundation
    Environmental Drivers of Clonal Hematopoiesis
    Role: Co-PI

    R01AI141716     (BALDRIDGE, MEGAN T)Nov 7, 2018 - Oct 31, 2023
    NIH
    Microbiota-dependent regulation of primitive hematopoieses
    Role Description: The goal of this study is to quantify the impact of a variety of environmental stressors on clonal dynamics of a panel of genetically distinct hematopoietic stem cell clones.
    Role: Co-PI

    R01HL134880     (KING, KATHERINE YUDEH)Aug 1, 2017 - Jun 30, 2021
    NIH
    Inflammatory Regulation of Hematopoietic Stem and Progenitor Cells to Enhance Innate Immunity
    Role: Principal Investigator

    R01HL136333     (KING, KATHERINE YUDEH)May 1, 2017 - Apr 30, 2023
    NIH
    The Contribution ofInfection to Preleukemic Clonal Hematopoiesis
    Role: Principal Investigator

    K08HL098898     (KING, KATHERINE YUDEH)May 1, 2010 - Feb 28, 2015
    NIH
    The Role of Interferon-gamma in the Regulation of Hematopoietic Stem Cells
    Role: Principal Investigator

    T32HL092332     (HESLOP, HELEN E)Jul 1, 2003 - Jul 31, 2028
    NIH
    Training In Cell and Gene Therapy
    Role: Co-Principal Investigator

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Seasock MJ, Shafiquzzaman M, Ruiz-Echartea ME, Kanchi RS, Tran BT, Simon LM, Meyer MD, Erice PA, Lotlikar SL, Wenlock SC, Ochsner SA, Enright A, Carisey AF, Romero F, Rosas IO, King KY, McKenna NJ, Coarfa C, Rodriguez A. Let-7 restrains an oncogenic epigenetic circuit in AT2 cells to prevent ectopic formation of fibrogenic transitional cell intermediates and pulmonary fibrosis. bioRxiv. 2024 May 27. PMID: 38826218; PMCID: PMC11142151.
      Citations:    
    2. Fernandez Sanchez JV, Maknojia AA, King KY, Fernandez Sanchez J, Maknojia AA, King KY. Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease. Blood. 2024 Apr 25; 143(17):1689-1701. PMID: 38364184; PMCID: PMC11103099.
      Citations:    Fields:    
    3. Cao R, Thatavarty A, King KY, Cao R, Thatavarty A, King KY. Forged in the fire: Lasting impacts of inflammation on hematopoietic progenitors. Exp Hematol. 2024 Jun; 134:104215. PMID: 38580008; PMCID: PMC11153002.
      Citations:    Fields:    Translation:HumansAnimalsCells
    4. Figueroa M, Ma H, Alfayez M, Morales-Mantilla DE, Wang F, Lu Y, Estecio MR, King KY, Kleinerman E, Moghaddam SJ, Daver N, Andreeff M, Konopleva M, DiNardo C, Chandra J. Cigarette smoke exposure accelerates AML progression in FLT3-ITD models. Blood Adv. 2023 11 14; 7(21):6624-6629. PMID: 37486624; PMCID: PMC10628807.
      Citations:    Fields:    Translation:Humans
    5. Tran BT, Cao R, King KY. Over but not gone: lingering epigenetic effects of COVID-19. Trends Immunol. 2023 10; 44(10):751-753. PMID: 37704548; PMCID: PMC10543559.
      Citations:    Fields:    Translation:HumansCells
    6. Roland D, Van Driest SL, Heerman WJ, King KY, Maitre NL, Fritz SA, Barkin S. Navigating success for early stage investigators-practical words of advice. Pediatr Res. 2023 09; 94(3):1248. PMID: 32555500.
      Citations:    
    7. Kain BN, Tran BT, Luna PN, Cao R, Le DT, Florez MA, Maneix L, Toups JD, Morales-Mantilla DE, Koh S, Han H, Jaksik R, Huang Y, Catic A, Shaw CA, King KY. Hematopoietic stem and progenitor cells confer cross-protective trained immunity in mouse models. iScience. 2023 Sep 15; 26(9):107596. PMID: 37664586; PMCID: PMC10470378.
      Citations: 2     
    8. Willis MB, King KY. Dismantling the tumoral cloak of self-protection. PLoS Biol. 2023 05; 21(5):e3002104. PMID: 37141182; PMCID: PMC10159154.
      Citations:    Fields:    Translation:Humans
    9. Le DT, Florez MA, Kus P, Tran BT, Kain B, Zhu Y, Christensen K, Jain A, Malovannaya A, King KY. BATF2 promotes HSC myeloid differentiation by amplifying IFN response mediators during chronic infection. iScience. 2023 Feb 17; 26(2):106059. PMID: 36824275; PMCID: PMC9942003.
      Citations: 1     
    10. Read JA, Rouce RH, Mo F, Mamonkin M, King KY. Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther. 2023 03; 29(3):165.e1-165.e7. PMID: 36592718; PMCID: PMC9991966.
      Citations:    Fields:    Translation:HumansAnimalsCells
    11. Bogeska R, Mikecin AM, Kaschutnig P, Fawaz M, Le D, Ganuza M, Vollmer A, Paffenholz SV, Asada N, Rodriguez-Correa E, Frauhammer F, Buettner F, Ball M, Knoch J, Walter D, Petri A, Wagner V, Brors B, Lipka DB, Essers MAG, Weru V, Holland-Letz T, Mallm JP, Rippe K, Schlesner M, McKinney Freeman S, Florian MC, King KY, Frenette PS, Rieger MA, Milsom MD, B?chler-Sch?ff M, St?ble S, Carre?o-Gonzalez MJ, Haas S, Kr?mer S. Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging. Cell Stem Cell. 2022 08 04; 29(8):1273-1284.e8. PMID: 35858618; PMCID: PMC9357150.
      Citations:    
    12. Morales-Mantilla DE, King KY. FGD5 marks a subpopulation of hematopoietic stem and progenitor cells that resist interferon-?-mediated differentiation. Exp Hematol. 2022 Aug-Sep; 112-113:35-43. PMID: 35768035.
      Citations:    Fields:    
    13. Florez MA, Tran BT, Wathan TK, DeGregori J, Pietras EM, King KY. Clonal hematopoiesis: Mutation-specific adaptation to environmental change. Cell Stem Cell. 2022 06 02; 29(6):882-904. PMID: 35659875; PMCID: PMC9202417.
      Citations:    Fields:    Translation:Cells
    14. Zhang CR, Ostrander EL, Kukhar O, Mallaney C, Sun J, Haussler E, Celik H, Koh WK, King KY, Gontarz P, Challen GA. Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21. Blood Cancer Discov. 2022 05 05; 3(3):220-239. PMID: 35394496; PMCID: PMC9414740.
      Citations:    
    15. Yan H, Walker FC, Ali A, Han H, Tan L, Veillon L, Lorenzi PL, Baldridge MT, King KY. The bacterial microbiota regulates normal hematopoiesis via metabolite-induced type 1 interferon signaling. Blood Adv. 2022 03 22; 6(6):1754-1765. PMID: 35143611; PMCID: PMC8941453.
      Citations:    Fields:    Translation:AnimalsCells
    16. Morales-Mantilla DE, Kain B, Le D, Flores AR, Paust S, King KY. Hematopoietic stem and progenitor cells improve survival from sepsis by boosting immunomodulatory cells. Elife. 2022 02 15; 11. PMID: 35166205; PMCID: PMC8846591.
      Citations:    Fields:    Translation:AnimalsCells
    17. Chen Y, Talukder R, Merritt BY, King KY, Kimmel M, Rivero G, Sosa R. Genomic trajectory in leukemogenesis of myeloproliferative neoplasms: a case report. BMC Med Genomics. 2021 05 22; 14(1):137. PMID: 34022887; PMCID: PMC8141236.
      Citations:    
    18. Hormaechea-Agulla D, Matatall KA, Le DT, Kain B, Long X, Kus P, Jaksik R, Challen GA, Kimmel M, King KY. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFN? signaling. Cell Stem Cell. 2021 08 05; 28(8):1428-1442.e6. PMID: 33743191; PMCID: PMC8349829.
      Citations: 34     Fields:    Translation:AnimalsCells
    19. Demerdash Y, Kain B, Essers MAG, King KY. Yin and Yang: The dual effects of interferons on hematopoiesis. Exp Hematol. 2021 04; 96:1-12. PMID: 33571568; PMCID: PMC8919039.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    20. Han H, Yan H, King KY. Broad-Spectrum Antibiotics Deplete Bone Marrow Regulatory T Cells. Cells. 2021 01 30; 10(2). PMID: 33573218; PMCID: PMC7911786.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    21. Florez MA, Matatall KA, Jeong Y, Ortinau L, Shafer PW, Lynch AM, Jaksik R, Kimmel M, Park D, King KY. Interferon Gamma Mediates Hematopoietic Stem Cell Activation and Niche Relocalization through BST2. Cell Rep. 2020 12 22; 33(12):108530. PMID: 33357430; PMCID: PMC7816211.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    22. Morales-Mantilla DE, Huang X, Erice P, Porter P, Zhang Y, Figueroa M, Chandra J, King KY, Kheradmand F, Rodr?guez A. Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System. J Vis Exp. 2020 10 22; (164). PMID: 33165327; PMCID: PMC7996447.
      Citations: 1     Fields:    Translation:AnimalsPHPublic Health
    23. Chen J, Matatall KA, Feng X, Hormaechea-Agulla D, Maharjan M, Young N, King KY. Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment. Exp Hematol. 2020 11; 91:39-45.e2. PMID: 32961298; PMCID: PMC7948254.
      Citations: 2     Fields:    Translation:AnimalsCells
    24. Hormaechea-Agulla D, Le DT, King KY. Common Sources of Inflammation and Their Impact on Hematopoietic Stem Cell Biology. Curr Stem Cell Rep. 2020; 6(3):96-107. PMID: 32837857; PMCID: PMC7429415.
      Citations: 7     
    25. King KY, Huang Y, Nakada D, Goodell MA. Environmental influences on clonal hematopoiesis. Exp Hematol. 2020 03; 83:66-73. PMID: 31893524; PMCID: PMC7103536.
      Citations: 18     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    26. Niles D, Boguniewicz J, Shakeel O, Margolin J, Chelius D, Gupta M, Paul D, King KY, McNeil JC. Candida tropicalis Thyroiditis Presenting With Thyroid Storm in a Pediatric Patient With Acute Lymphocytic Leukemia. Pediatr Infect Dis J. 2019 10; 38(10):1051-1053. PMID: 31365478.
      Citations: 1     Fields:    Translation:HumansAnimals
    27. Zeng H, He H, Guo L, Li J, Lee M, Han W, Guzman AG, Zang S, Zhou Y, Zhang X, Goodell MA, King KY, Sun D, Huang Y. Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies. Cancer Lett. 2019 12 28; 467:1-8. PMID: 31563562; PMCID: PMC6945766.
      Citations: 8     Fields:    Translation:AnimalsCells
    28. Foster CE, Taylor M, Schallert EK, Rosenfeld S, King KY. Brodie Abscess in Children: A 10-Year Single Institution Retrospective Review. Pediatr Infect Dis J. 2019 02; 38(2):e32-e34. PMID: 29620720.
      Citations: 3     Fields:    Translation:Humans
    29. Kennedy EA, King KY, Baldridge MT. Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria. Front Physiol. 2018; 9:1534. PMID: 30429801; PMCID: PMC6220354.
      Citations: 129     
    30. Morales-Mantilla DE, King KY. The Role of Interferon-Gamma in Hematopoietic Stem Cell Development, Homeostasis, and Disease. Curr Stem Cell Rep. 2018; 4(3):264-271. PMID: 30148048; PMCID: PMC6096761.
      Citations: 30     
    31. Yan H, Baldridge MT, King KY. Hematopoiesis and the bacterial microbiome. Blood. 2018 08 09; 132(6):559-564. PMID: 29853538; PMCID: PMC6085989.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    32. Kitagawa MG, Ettinger N, Breen D, Erklauer J, Chang E, Herce H, King K, Naik S. Transmission of West Nile Virus Through a Hematopoietic Stem Cell Transplant. J Pediatric Infect Dis Soc. 2018 May 15; 7(2):e52-e54. PMID: 29309636.
      Citations: 1     Fields:    Translation:Humans
    33. Tashi T, Swierczek S, Kim SJ, Salama ME, Song J, Heikal N, King KY, Hickman K, Litton S, Prchal JT. Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses. Leukemia. 2018 08; 32(8):1830-1833. PMID: 29556018; PMCID: PMC6552660.
      Citations: 7     Fields:    Translation:HumansCells
    34. Matatall KA, Kadmon CS, King KY. Detecting Hematopoietic Stem Cell Proliferation Using BrdU Incorporation. Methods Mol Biol. 2018; 1686:91-103. PMID: 29030815; PMCID: PMC6020038.
      Citations: 7     Fields:    Translation:HumansCells
    35. King KY. Saving Stem Cells after Stress. Cell Stem Cell. 2017 12 07; 21(6):709-710. PMID: 29220661.
      Citations:    Fields:    Translation:Cells
    36. Kadmon CS, Landers CT, Li HS, Watowich SS, Rodriguez A, King KY. MicroRNA-22 controls interferon alpha production and erythroid maturation in response to infectious stress in mice. Exp Hematol. 2017 12; 56:7-15. PMID: 28911907; PMCID: PMC5696003.
      Citations: 10     Fields:    Translation:AnimalsCells
    37. Matatall KA, Jeong M, Chen S, Sun D, Chen F, Mo Q, Kimmel M, King KY. Chronic Infection Depletes Hematopoietic Stem Cells through Stress-Induced Terminal Differentiation. Cell Rep. 2016 12 06; 17(10):2584-2595. PMID: 27926863; PMCID: PMC5161248.
      Citations: 88     Fields:    Translation:HumansAnimalsCells
    38. Josefsdottir KS, Baldridge MT, Kadmon CS, King KY. Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota. Blood. 2017 02 09; 129(6):729-739. PMID: 27879260; PMCID: PMC5301822.
      Citations: 114     Fields:    Translation:AnimalsCells
    39. Luis TC, Tremblay CS, Manz MG, North TE, King KY, Challen GA. Inflammatory signals in HSPC development and homeostasis: Too much of?a?good thing? Exp Hematol. 2016 10; 44(10):908-12. PMID: 27423816; PMCID: PMC6552661.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    40. Li HS, Jin J, Liang X, Matatall KA, Ma Y, Zhang H, Ullrich SE, King KY, Sun SC, Watowich SS. Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice. Eur J Haematol. 2016 Sep; 97(3):261-70. PMID: 26660446; PMCID: PMC5680037.
      Citations: 4     Fields:    Translation:AnimalsCells
    41. King KY, Matatall KA, Shen CC, Goodell MA, Swierczek SI, Prchal JT. Comparative long-term effects of interferon a and hydroxyurea on human hematopoietic progenitor cells. Exp Hematol. 2015 Oct; 43(10):912-918.e2. PMID: 26072330; PMCID: PMC4592796.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    42. King KY, Hicks MJ, Mazziotti MV, Eldin KW, Starke JR, Michael M. Persistent cat scratch disease requiring surgical excision in a patient with MPGN. Pediatrics. 2015 Jun; 135(6):e1514-7. PMID: 25963015.
      Citations: 2     Fields:    Translation:Humans
    43. Josefsdottir KS, King KY. Interferons coordinate a multifaceted defense. Cell Host Microbe. 2015 Jan 14; 17(1):6-7. PMID: 25590754.
      Citations:    Fields:    Translation:AnimalsCells
    44. Trompouki E, King KY, Will B, Flores-Figueroa E, Kokkaliaris KD, Bowman T, Lessard J. Bloody signals: from birth to disease and death. Exp Hematol. 2014 Dec; 42(12):989-94. PMID: 25482344.
      Citations:    Fields:    Translation:HumansAnimalsCells
    45. Matatall KA, Shen CC, Challen GA, King KY. Type II interferon promotes differentiation of myeloid-biased hematopoietic stem cells. Stem Cells. 2014 Nov; 32(11):3023-30. PMID: 25078851; PMCID: PMC4198460.
      Citations: 56     Fields:    Translation:AnimalsCells
    46. Rodgers JT, King KY, Brett JO, Cromie MJ, Charville GW, Maguire KK, Brunson C, Mastey N, Liu L, Tsai CR, Goodell MA, Rando TA. mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert). Nature. 2014 Jun 19; 510(7505):393-6. PMID: 24870234; PMCID: PMC4065227.
      Citations: 277     Fields:    Translation:AnimalsCells
    47. Rossi L, Lin KK, Boles NC, Yang L, King KY, Jeong M, Mayle A, Goodell MA. Less is more: unveiling the functional core of hematopoietic stem cells through knockout mice. Cell Stem Cell. 2012 Sep 07; 11(3):302-17. PMID: 22958929; PMCID: PMC3461270.
      Citations: 108     Fields:    Translation:AnimalsCells
    48. King KY, Goodell MA. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol. 2011 Sep 09; 11(10):685-92. PMID: 21904387; PMCID: PMC4154310.
      Citations: 241     Fields:    Translation:HumansAnimalsCells
    49. King KY, Baldridge MT, Weksberg DC, Chambers SM, Lukov GL, Wu S, Boles NC, Jung SY, Qin J, Liu D, Songyang Z, Eissa NT, Taylor GA, Goodell MA. Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling. Blood. 2011 Aug 11; 118(6):1525-33. PMID: 21633090; PMCID: PMC3156044.
      Citations: 48     Fields:    Translation:HumansAnimalsCells
    50. King KY, Goodell MA. Direct conversion of skin cells into blood: alchemy or science? Mol Ther. 2011 Feb; 19(2):227-8. PMID: 21289635; PMCID: PMC3034862.
      Citations:    Fields:    Translation:HumansAnimalsCells
    51. King KY, Lew JD, Ha NP, Lin JS, Ma X, Graviss EA, Goodell MA. Polymorphic allele of human IRGM1 is associated with susceptibility to tuberculosis in African Americans. PLoS One. 2011 Jan 21; 6(1):e16317. PMID: 21283700; PMCID: PMC3025014.
      Citations: 41     Fields:    Translation:Humans
    52. Baldridge MT, King KY, Goodell MA. Inflammatory signals regulate hematopoietic stem cells. Trends Immunol. 2011 Feb; 32(2):57-65. PMID: 21233016; PMCID: PMC3042730.
      Citations: 170     Fields:    Translation:HumansAnimalsCells
    53. Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature. 2010 Jun 10; 465(7299):793-7. PMID: 20535209; PMCID: PMC2935898.
      Citations: 398     Fields:    Translation:AnimalsCells
    54. King KY, Edwards MS, Word BM. Hepatitis associated with micafungin use in a preterm infant. J Perinatol. 2009 Apr; 29(4):320-2. PMID: 19325554.
      Citations: 3     Fields:    Translation:Humans
    55. King K, Browning JC, Metry DW, Prestigiacomo J, Scollard D, Schutze GE, Stryjewska B, Schwarzwald H. Leprosy and international adoption: a case report and review of diagnostic and treatment dilemmas. Pediatr Infect Dis J. 2009 Apr; 28(4):322-5. PMID: 19238115.
      Citations: 3     Fields:    Translation:Humans
    56. Brenot A, King KY, Caparon MG. The PerR regulon in peroxide resistance and virulence of Streptococcus pyogenes. Mol Microbiol. 2005 Jan; 55(1):221-34. PMID: 15612930.
      Citations: 70     Fields:    Translation:AnimalsCells
    57. Brenot A, King KY, Janowiak B, Griffith O, Caparon MG. Contribution of glutathione peroxidase to the virulence of Streptococcus pyogenes. Infect Immun. 2004 Jan; 72(1):408-13. PMID: 14688122; PMCID: PMC344014.
      Citations: 59     Fields:    Translation:HumansAnimalsCells
    58. King KY, Horenstein JA, Caparon MG. Aerotolerance and peroxide resistance in peroxidase and PerR mutants of Streptococcus pyogenes. J Bacteriol. 2000 Oct; 182(19):5290-9. PMID: 10986229; PMCID: PMC110969.
      Citations: 61     Fields:    Translation:Cells
    59. Smith RF, King KY. Identification of a eukaryotic-like protein kinase gene in Archaebacteria. Protein Sci. 1995 Jan; 4(1):126-9. PMID: 7773169; PMCID: PMC2142968.
      Citations: 11     Fields:    Translation:Cells
    60. Worley KC, King KY, Chua S, McCabe ER, Smith RF. Identification of new members of a carbohydrate kinase-encoding gene family. J Comput Biol. 1995; 2(3):451-8. PMID: 8521274.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    KING's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (302)
    Explore
    _
    Co-Authors (55)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _